Parametric Portfolio Associates’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$707K	Sell	73,983 -623	-0.8%	-$6.11K	﹤0.01%	2939
2021 Q4	$824K	Buy	74,606 +29,278	+65%	+$255K	﹤0.01%	2863
2021 Q3	$335K	Buy	45,328 +24,028	+113%	+$269K	﹤0.01%	3257
2021 Q2	$309K	Buy	21,300 +1,097	+5%	+$20.6K	﹤0.01%	3264
2021 Q1	$412K	Sell	20,203 -1,554	-7%	-$29.5K	﹤0.01%	3584
2020 Q4	$387K	Sell	21,757 -2,664	-11%	-$47.8K	﹤0.01%	3493
2020 Q3	$361K	Sell	24,421 -60,855	-71%	-$1.14M	﹤0.01%	3410
2020 Q2	$1.79M	Buy	85,276 +28,108	+49%	+$722K	﹤0.01%	2565
2020 Q1	$1.32M	Buy	57,168 +25,692	+82%	+$643K	﹤0.01%	2625
2019 Q4	$815K	Sell	31,476 -24,097	-43%	-$468K	﹤0.01%	3159
2019 Q3	$1.08M	Buy	55,573 +37,022	+200%	+$748K	﹤0.01%	2977
2019 Q2	$303K	Sell	18,551 -2,570	-12%	-$52.1K	﹤0.01%	3578
2019 Q1	$479K	Buy	21,121 +1,139	+6%	+$28.9K	﹤0.01%	3360
2018 Q4	$511K	Buy	19,982 +4,659	+30%	+$126K	﹤0.01%	3299
2018 Q3	$501K	Buy	15,323 +2,184	+17%	+$59.5K	﹤0.01%	3417
2018 Q2	$298K	Sell	13,139 -15,543	-54%	-$369K	﹤0.01%	3558
2018 Q1	$696K	Buy	28,682 +9,248	+48%	+$254K	﹤0.01%	3190
2017 Q4	$542K	Buy	19,434 +4,642	+31%	+$137K	﹤0.01%	3286
2017 Q3	$506K	Buy	14,792 +549	+4%	+$18K	﹤0.01%	3417
2017 Q2	$567K	Buy	14,243 +153	+1%	+$5.88K	﹤0.01%	3292
2017 Q1	$519K	Buy	14,090 +456	+3%	+$14.6K	﹤0.01%	3190
2016 Q4	$435K	Buy	13,634 +1,063	+8%	+$33K	﹤0.01%	3263
2016 Q3	$456K	Sell	12,571 -1,531	-11%	-$42.6K	﹤0.01%	3217
2016 Q2	$320K	Buy	14,102 +3,314	+31%	+$71.6K	﹤0.01%	3426
2016 Q1	$203K	Sell	10,788 -524	-5%	-$8.57K	﹤0.01%	3737
2015 Q4	$185K	Buy	+11,312	New	+$180K	﹤0.01%	3751

Other funds holding TBPH